Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|October 2, 2024
INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: a potential application to increase the efficacy of NK adoptive cell therapy against cancerMelissa Maxwell, Dingxue Yan, Brianna Rivest, et al.Cancers|September 9, 2022
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)Chen Lyu, Lili Wang, Birgit Stadlbauer, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1Dilip Kumar, Judith Hosse, Christine von Toerne, et al.Human Gene Therapy|July 8, 2005
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genesBoris Engels, Elfriede Noessner, Bernhard Frankenberger, et al.The Journal of Investigative Dermatology|October 26, 2012
Treatment of dermal fibroblasts with GPI-anchored human TIMP-1 protein moderates processes linked to scar formationRoghieh Djafarzadeh, Susan Notohamiprodjo, Nicole Rieth, et al.International Immunology|February 28, 2016
A novel role of MMP-13 for murine DC function: its inhibition dampens T-cell activationJuliane Bartmann, Marion Frankenberger, Claus Neurohr, et al.Frontiers in Immunology|December 16, 2021
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell TherapyLuis Felipe Olguín-Contreras, Anna N Mendler, Grzegorz Popowicz, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2012
High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic interventionPetra U Prinz, Anna N Mendler, Ilias Masouris, et al.International Journal of Cancer|September 8, 2011
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activationAnna N Mendler, Bin Hu, Petra U Prinz, et al.Oncoimmunology|December 18, 2012
Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinomaElfriede Noessner, Dorothee Brech, Anna N Mendler, et al.Pageof 8